Stroke device trial pulled before it even started

NCT ID NCT06386289

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This trial was designed to test a device called the CEREGLIDE 92 catheter, which aims to remove large blood clots from the brain in people having a severe stroke. The study planned to enroll patients with acute ischemic stroke and high disability scores. However, the trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CEREGLIDE 92 intermediate catheter

What this could lead to

If successful, this device could improve blood flow restoration in stroke patients with a single pass, potentially reducing brain damage and disability.

What could go wrong

The trial was withdrawn before enrolling any participants, so no data is available. The device may not work as intended or could cause complications like vessel damage or bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.